STOCK TITAN

SI-BONE CEO Laura Francis sells 16,854 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

SI-BONE, Inc. Chief Executive Officer Laura Francis reported six direct sales totaling 16,854 shares on November 16–17, 2026. Five November 16 sales were required to cover tax withholding tied to restricted stock unit vesting and were described as not discretionary. Her 1,901-share November 17 sale had a weighted average price of $23.1763 per share and was made under a 10b5-1 trading plan dated June 13, 2025. Separately, The David & Laura Joint Rev Tr. was listed as holding 304,256 shares on November 16.

Insider FRANCIS LAURA
Role Chief Executive Officer
Sold 16,854 shs ($393K)
Type Security Shares Price Value
Sale Common Stock F7, F8, F9 1,901 $23.1763 $44K
Sale Common Stock F1, F2 3,892 $23.3331 $91K
Sale Common Stock F1, F3 2,235 $23.3256 $52K
Sale Common Stock F1, F4 3,203 $23.3229 $75K
Sale Common Stock F1, F5 3,651 $23.3321 $85K
Sale Common Stock F1, F6 1,972 $23.3191 $46K
Holding Common Stock F10 -- -- --
Holdings After Transaction: Common Stock — 351,275 shares (Direct); Common Stock — 304,256 shares (Indirect, by Trust)
Footnotes (10)
  1. F1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  2. F10. Shares held by The David & Laura Joint Rev Tr.
  3. F2. This transaction was executed in multiple trades at prices ranging from $23.25 USD to $23.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F3. This transaction was executed in multiple trades at prices ranging from $23.28 USD to $23.40 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F4. This transaction was executed in multiple trades at prices ranging from $23.30 USD to $23.44 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F5. This transaction was executed in multiple trades at prices ranging from $23.26 USD to $23.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. F6. This transaction was executed in multiple trades at prices ranging from $23.27 USD to $23.38 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F7. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13, 2025.
  9. F8. This transaction was executed in multiple trades at prices ranging from $23.03 USD to $23.43 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. F9. Includes 326,327 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Shares sold across six direct transactions 16,854 shares November 16–17, 2026
Shares sold November 17 1,901 shares Weighted average sale price was $23.1763 per share
Weighted average sale price $23.1763 per share November 17, 2026 sale
Trading plan date June 13, 2025 Plan governing the November 17 sale
Shares held by The David & Laura Joint Rev Tr. 304,256 shares November 16, 2026
Shares issuable on RSU settlement 326,327 shares Restricted stock units granted to Laura Francis
sell to cover transaction financial
"tax withholding obligations to be funded by a sell to cover transaction"
restricted stock units financial
"vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 trading plan regulatory
"effected pursuant to a 10b5-1 trading plan dated June 13, 2025"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
weighted average sale price financial
"the price reported above reflects the weighted average sale price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did SIBN CEO Laura Francis sell?

Laura Francis reported 16,854 shares sold across six direct transactions on November 16 and 17, 2026. Her November 17 sale covered 1,901 shares at a weighted average $23.1763 per share; the November 16 transactions had separate reported prices.

Why did SIBN CEO Laura Francis sell shares on November 16?

The five November 16 transactions were required sell-to-cover sales for tax withholding connected with restricted stock unit vesting; the footnote says they did not represent discretionary trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FRANCIS LAURA

(Last)(First)(Middle)
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101

(Street)
SANTA CLARA CALIFORNIA 95134

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SI-BONE, Inc. [ SIBN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026S(1)3,892D$23.3331(2)364,237D
Common Stock11/16/2026S(1)2,235D$23.3256(3)362,002D
Common Stock11/16/2026S(1)3,203D$23.3229(4)358,799D
Common Stock11/16/2026S(1)3,651D$23.3321(5)355,148D
Common Stock11/16/2026S(1)1,972D$23.3191(6)353,176D
Common Stock11/17/2026S(7)1,901D$23.1763(8)351,275(9)D
Common Stock304,256Iby Trust(10)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
2. This transaction was executed in multiple trades at prices ranging from $23.25 USD to $23.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. This transaction was executed in multiple trades at prices ranging from $23.28 USD to $23.40 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. This transaction was executed in multiple trades at prices ranging from $23.30 USD to $23.44 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. This transaction was executed in multiple trades at prices ranging from $23.26 USD to $23.42 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. This transaction was executed in multiple trades at prices ranging from $23.27 USD to $23.38 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13, 2025.
8. This transaction was executed in multiple trades at prices ranging from $23.03 USD to $23.43 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. Includes 326,327 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
10. Shares held by The David & Laura Joint Rev Tr.
Remarks:
/s/ Michael A. Pisetsky, Attorney-in-Fact for Laura A. Francis11/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading